Analyst Price Targets — MDGL
Latest News for MDGL
Artisan Partners Limited Partnership grew its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) by 2.3% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 206,254 shares of the biopharmaceutical company's stock after purchasing an additional 4,683 shares during the quarter. Artisan
CONSHOHOCKEN, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 2:30 P.M.
MDGL swings to a wider Q4 loss as expenses surge, but Rezdiffra sales top estimates and fuel revenue growth. The stock slides 11% in response to the mixed nature of the results.
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL - Get Free Report)'s stock price gapped down before the market opened on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $491.49, but opened at $452.02. Madrigal Pharmaceuticals shares last traded at $450.3060, with a volume of 428,933 shares. The biopharmaceutical company reported ($2.57) earnings
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MDGL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.